BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 36768111)

  • 21. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
    Götze TO; Piso P; Lorenzen S; Bankstahl US; Pauligk C; Elshafei M; Amato G; Reim D; Bechstein WO; Königsrainer A; Mönig SP; Rau B; Schwarzbach M; Al-Batran SE
    BMC Cancer; 2021 Oct; 21(1):1158. PubMed ID: 34715810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dynamic nomogram for predicting diabetic macular edema in type 2 diabetes patients based on plasma cytokines.
    Zhang N; Ke J; Zhang D; Zhang Y; Fu Y; Cao B; Zhao D
    Aging (Albany NY); 2021 Mar; 13(6):8369-8379. PubMed ID: 33686950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment and recent progress in gastric cancer.
    Joshi SS; Badgwell BD
    CA Cancer J Clin; 2021 May; 71(3):264-279. PubMed ID: 33592120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Treatment Sequencing on Survival for Patients with Locally Advanced Gastric Cancer.
    Li SS; Klempner SJ; Costantino CL; Parikh A; Clark JW; Wo JY; Hong TS; Mullen JT
    Ann Surg Oncol; 2021 May; 28(5):2856-2865. PubMed ID: 33393043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
    Park SH; Lim DH; Sohn TS; Lee J; Zang DY; Kim ST; Kang JH; Oh SY; Hwang IG; Ji JH; Shin DB; Yu JI; Kim KM; An JY; Choi MG; Lee JH; Kim S; Hong JY; Park JO; Park YS; Lim HY; Bae JM; Kang WK;
    Ann Oncol; 2021 Mar; 32(3):368-374. PubMed ID: 33278599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial.
    de Steur WO; van Amelsfoort RM; Hartgrink HH; Putter H; Meershoek-Klein Kranenbarg E; van Grieken NCT; van Sandick JW; Claassen YHM; Braak JPBM; Jansen EPM; Sikorska K; van Tinteren H; Walraven I; Lind P; Nordsmark M; van Berge Henegouwen MI; van Laarhoven HWM; Cats A; Verheij M; van de Velde CJH;
    Ann Oncol; 2021 Mar; 32(3):360-367. PubMed ID: 33227408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of MRI in the diagnosis and treatment of gastric cancer.
    Zhang Y; Yu J
    Diagn Interv Radiol; 2020 May; 26(3):176-182. PubMed ID: 32209504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram for predicting overall survival in stage II-III colorectal cancer.
    Liu J; Huang X; Yang W; Li C; Li Z; Zhang C; Chen S; Wu G; Xie W; Wei C; Tian C; Huang L; Jeen F; Mo X; Tang W
    Cancer Med; 2020 Apr; 9(7):2363-2371. PubMed ID: 32027098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors and Risk Scores for Predicting Early Recurrence After Curative Gastrectomy in Patients with Stage III Gastric Cancer.
    Wakatsuki K; Matsumoto S; Migita K; Kunishige T; Nakade H; Miyao S; Sho M
    J Gastrointest Surg; 2020 Aug; 24(8):1758-1769. PubMed ID: 31325135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
    Qiu MZ; Shi SM; Chen ZH; Yu HE; Sheng H; Jin Y; Wang DS; Wang FH; Li YH; Xie D; Zhou ZW; Yang DJ; Xu RH
    Cancer Med; 2018 Aug; 7(8):3662-3672. PubMed ID: 29984918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic gastric cancer: Does the site of metastasis make a difference?
    Tan HL; Chia CS; Tan GHC; Choo SP; Tai DW; Chua CWL; Ng MCH; Soo KC; Teo MCC
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):10-17. PubMed ID: 29920947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.
    Nieder C; Mehta MP; Geinitz H; Grosu AL
    Crit Rev Oncol Hematol; 2018 Jun; 126():13-18. PubMed ID: 29759555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomograms are key decision-making tools in prostate cancer radiation therapy.
    Caulfield S; Menezes G; Marignol L; Poole C
    Urol Oncol; 2018 Jun; 36(6):283-292. PubMed ID: 29680180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography.
    Kim SM; Kim Y; Jeong K; Jeong H; Kim J
    Ultrasonography; 2018 Jan; 37(1):36-42. PubMed ID: 28618771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis.
    Mikami J; Kimura Y; Makari Y; Fujita J; Kishimoto T; Sawada G; Nakahira S; Nakata K; Tsujie M; Ohzato H
    World J Surg Oncol; 2017 Jan; 15(1):8. PubMed ID: 28061855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Chao J; Das P; Denlinger CS; Fanta P; Farjah F; Fuchs CS; Gerdes H; Gibson M; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Johung KL; Keswani RN; Kleinberg LR; Korn WM; Leong S; Linn C; Lockhart AC; Ly QP; Mulcahy MF; Orringer MB; Perry KA; Poultsides GA; Scott WJ; Strong VE; Washington MK; Weksler B; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H
    J Natl Compr Canc Netw; 2016 Oct; 14(10):1286-1312. PubMed ID: 27697982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
    Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
    Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lauren classification and individualized chemotherapy in gastric cancer.
    Ma J; Shen H; Kapesa L; Zeng S
    Oncol Lett; 2016 May; 11(5):2959-2964. PubMed ID: 27123046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study.
    Zhao LY; Zhang WH; Chen XZ; Yang K; Chen XL; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Medicine (Baltimore); 2015 Dec; 94(50):e2288. PubMed ID: 26683961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.